Patent delisted for Boehringer Ingelheim drug TRIJARDY XR

Annual Drug Patent Expirations for TRIJARDY+XR Trijardy Xr is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are fifteen…

The post Patent delisted for Boehringer Ingelheim drug TRIJARDY XR appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Do NOT follow this link or you will be banned from the site!